Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Lipkowitz

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Cancers|August 3, 2019
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the ToolboxBora Lim, Yoshimi Greer, Stanley Lipkowitz, et al.
Nature Structural & Molecular Biology|February 4, 2012
Cbl exposes its RING fingerStephen C Kales, Philip E Ryan, Stanley Lipkowitz
Breast Disease|July 23, 2011
Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancerKathryn J Chavez, Sireesha V Garimella, Stanley Lipkowitz
BMJ Case Reports|September 4, 2021
Acute eosinophilic pneumonia: a fatal reaction to ado-trastuzumabDaniel LaMorte, Daniel Desmond, John Ellis, et al.
Cells|December 11, 2022
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer TherapyManjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, et al.
JNCI Cancer Spectrum|February 24, 2025
Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancerToru Yoshino, Zao Zhang, Ryota Sato, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|June 4, 2016
Mathematical models of breast and ovarian cancersDana-Adriana Botesteanu, Stanley Lipkowitz, Jung-Min Lee, et al.
Current Treatment Options in Oncology|April 13, 2018
Update on PARP Inhibitors in Breast CancerAlexandra S Zimmer, Mitchell Gillard, Stanley Lipkowitz, et al.
Cancer Research|May 27, 2010
Cbl and human myeloid neoplasms: the Cbl oncogene comes of ageStephen C Kales, Philip E Ryan, Marion M Nau, et al.
Trends in Biochemical Sciences|January 13, 2006
Regulating the regulator: negative regulation of Cbl ubiquitin ligasesPhilip E Ryan, Gareth C Davies, Marion M Nau, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Cancers|August 3, 2019
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the ToolboxBora Lim, Yoshimi Greer, Stanley Lipkowitz, et al.
Nature Structural & Molecular Biology|February 4, 2012
Cbl exposes its RING fingerStephen C Kales, Philip E Ryan, Stanley Lipkowitz
Breast Disease|July 23, 2011
Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancerKathryn J Chavez, Sireesha V Garimella, Stanley Lipkowitz
BMJ Case Reports|September 4, 2021
Acute eosinophilic pneumonia: a fatal reaction to ado-trastuzumabDaniel LaMorte, Daniel Desmond, John Ellis, et al.
Cells|December 11, 2022
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer TherapyManjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, et al.
JNCI Cancer Spectrum|February 24, 2025
Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancerToru Yoshino, Zao Zhang, Ryota Sato, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|June 4, 2016
Mathematical models of breast and ovarian cancersDana-Adriana Botesteanu, Stanley Lipkowitz, Jung-Min Lee, et al.
Current Treatment Options in Oncology|April 13, 2018
Update on PARP Inhibitors in Breast CancerAlexandra S Zimmer, Mitchell Gillard, Stanley Lipkowitz, et al.
Cancer Research|May 27, 2010
Cbl and human myeloid neoplasms: the Cbl oncogene comes of ageStephen C Kales, Philip E Ryan, Marion M Nau, et al.
Trends in Biochemical Sciences|January 13, 2006
Regulating the regulator: negative regulation of Cbl ubiquitin ligasesPhilip E Ryan, Gareth C Davies, Marion M Nau, et al.
Pageof 11